ArticleACS medicinal chemistry letters2025

Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.